Cargando…
Purinergic Signaling and Cochlear Injury-Targeting the Immune System?
Hearing impairment is the most common sensory deficit, affecting more than 400 million people worldwide. Sensorineural hearing losses currently lack any specific or efficient pharmacotherapy largely due to the insufficient knowledge of the pathomechanism. Purinergic signaling plays a substantial rol...
Autores principales: | Köles, László, Szepesy, Judit, Berekméri, Eszter, Zelles, Tibor |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6627352/ https://www.ncbi.nlm.nih.gov/pubmed/31216722 http://dx.doi.org/10.3390/ijms20122979 |
Ejemplares similares
-
Postnatal Development of the Subcellular Structures and Purinergic Signaling of Deiters’ Cells along the Tonotopic Axis of the Cochlea
por: Berekméri, Eszter, et al.
Publicado: (2019) -
Purinergic–Glycinergic Interaction in Neurodegenerative and Neuroinflammatory Disorders of the Retina
por: Harsing, Laszlo G., et al.
Publicado: (2021) -
Ca(2+) Dynamics of Gap Junction Coupled and Uncoupled Deiters’ Cells in the Organ of Corti in Hearing BALB/c Mice
por: Moysan, Louise, et al.
Publicado: (2023) -
Anti-PD-1 Therapy Does Not Influence Hearing Ability in the Most Sensitive Frequency Range, but Mitigates Outer Hair Cell Loss in the Basal Cochlear Region
por: Szepesy, Judit, et al.
Publicado: (2020) -
Chronic Oral Selegiline Treatment Mitigates Age-Related Hearing Loss in BALB/c Mice
por: Szepesy, Judit, et al.
Publicado: (2021)